Shenzhen Chipscreen Biosciences Hits Day High with 4.44% Surge

Shenzhen Chipscreen Biosciences Co., Ltd. has experienced a notable increase of 4.44% on March 10, 2026, reaching an intraday high of CNY 31.60. This performance stands out against the backdrop of the China Shanghai Composite, which only gained 0.65% on the same day. Over the past week, Shenzhen Chipscreen has shown a robust performance with a 5.67% increase, significantly outperforming the composite index, which saw a mere 0.01% rise. In terms of annual performance, Shenzhen Chipscreen has delivered an impressive return of 64.27%, far exceeding the China Shanghai Composite's 22.49%. However, the company has faced challenges in long-term growth, with net sales growing at an annual rate of 29.71% and operating profit showing a decline of 291.25% over the last five years. Despite these hurdles, recent quarterly results have indicated a positive turnaround, with a remarkable growth in pre-tax profit and net profit. With a market capitalization of CNY 13,091 million, Shenzhen Chipscreen operates within the pharmaceuticals and biotechnology sector, showcasing a complex financial landscape marked by both significant gains and underlying challenges.